Harvard Bioscience, Inc. (HBIO)

USD 2.03

(-6.45%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 137.36 Million 145.36 Million 162.34 Million 156.25 Million 164.87 Million 168.07 Million
Total Current Assets 49.03 Million 51.12 Million 61.58 Million 51.7 Million 53.57 Million 54.72 Million
Cash And Short Term Investments 4.28 Million 4.5 Million 7.82 Million 8.31 Million 8.33 Million 8.17 Million
Cash and Cash Equivalents 4.28 Million 4.5 Million 7.82 Million 8.31 Million 8.33 Million 8.17 Million
Short Term Investments - - - - - -
Net Receivables 16.09 Million 16.7 Million 21.83 Million 17.76 Million 20.7 Million 21.46 Million
Inventory 24.71 Million 26.43 Million 27.58 Million 22.26 Million 22.06 Million 25.08 Million
Other Current Assets 3.94 Million 3.47 Million 4.34 Million 3.35 Million 2.47 Million 3.1 Million
Total Non-Current Assets 88.32 Million 94.23 Million 100.76 Million 104.55 Million 111.29 Million 113.35 Million
Net PPE 8.75 Million 3.36 Million 3.41 Million 3.96 Million 4.77 Million 5.89 Million
Good Will And Intangible Assets 73.1 Million 77.27 Million 85.07 Million 91.74 Million 95.78 Million 102.52 Million
Good Will 57.06 Million 56.26 Million 57.68 Million 58.59 Million 57.38 Million 57.3 Million
Intangible Assets 16.03 Million 21.01 Million 27.38 Million 33.15 Million 38.4 Million 45.76 Million
Long-Term Investments - -333 Thousand -1.55 Million -255 Thousand -251 Thousand -211 Thousand
Tax Assets 436 Thousand 333 Thousand 1.55 Million 255 Thousand 251 Thousand 211 Thousand
Other Non Current Assets 6.03 Million 13.59 Million 12.27 Million 8.85 Million 10.73 Million 4.92 Million
Other Assets - - - - - -
Total Liabilities 64.29 Million 73.14 Million 78.94 Million 79.57 Million 83.17 Million 85.88 Million
Total Current Liabilities 26.54 Million 23.24 Million 25.31 Million 21.05 Million 25.31 Million 21.5 Million
Account Payables 5.55 Million 6.44 Million 4.91 Million 5.97 Million 5.33 Million 7.35 Million
Tax Payables - - 224 Thousand 286 Thousand 954 Thousand 1.4 Million
Short Term Debt 7.27 Million 3.81 Million 3.23 Million 1.72 Million 6.9 Million 1.99 Million
Deferred Revenue 7.7 Million 3.37 Million 4.26 Million 3.77 Million 3.94 Million 4.19 Million
Other Current Liabilities 6 Million 9.62 Million 12.9 Million 9.58 Million 9.12 Million 7.95 Million
Total Non Current Liabilities 37.75 Million 49.89 Million 53.62 Million 58.52 Million 57.86 Million 64.38 Million
Long-Term Debt 30.7 Million 43.01 Million 45.09 Million 46.28 Million 46.91 Million 58.79 Million
Deferred Revenue Non Current 4.79 Million - -1.55 Million -1.89 Million -1.97 Million -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.47 Million 6.28 Million 8.53 Million 12.23 Million 10.94 Million 3.28 Million
Other Liabilities - - - - - -
Total Equity 73.07 Million 72.22 Million 83.4 Million 76.68 Million 81.69 Million 82.18 Million
Stock Holders Equity 73.07 Million 72.22 Million 83.4 Million 76.68 Million 81.69 Million 82.18 Million
Common Stock 434 Thousand 454 Thousand 452 Thousand 444 Thousand 438 Thousand 436 Thousand
Retained Earnings -145.6 Million -142.19 Million -132.67 Million -132.38 Million -124.57 Million -119.88 Million
Accumulated other comprehensive income -14.19 Million -15.05 Million -10.02 Million -13.06 Million -12.68 Million -13.53 Million
Common Stock Equity 73.07 Million 72.22 Million 83.4 Million 76.68 Million 81.69 Million 82.18 Million
Capital Lease Obligation 4.79 Million 7.41 Million 8.63 Million 9.59 Million 10.64 Million -
Total Investments - -333 Thousand -1.55 Million -255 Thousand -251 Thousand -211 Thousand
Total Debt 42.77 Million 46.82 Million 48.33 Million 48 Million 53.81 Million 60.79 Million
Net Debt 38.49 Million 42.31 Million 40.5 Million 39.69 Million 45.48 Million 52.62 Million

Balance Sheet Charts